Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel

dc.contributor.authorWatkins, David A.en
dc.contributor.authorBeaton, Andrea Z.en
dc.contributor.authorCarapetis, Jonathan R.en
dc.contributor.authorKarthikeyan, Ganesanen
dc.contributor.authorMayosi, Bongani M.en
dc.contributor.authorWyber, Rosemaryen
dc.contributor.authorYacoub, Magdi H.en
dc.contributor.authorZühlke, Liesl J.en
dc.date.accessioned2025-12-16T21:41:06Z
dc.date.available2025-12-16T21:41:06Z
dc.date.issued2018-09-18en
dc.description.abstractRheumatic heart disease (RHD) is a preventable heart condition that remains endemic among vulnerable groups in many countries. After a period of relative neglect, there has been a resurging interest in RHD worldwide over the past decade. In this Scientific Expert Panel, the authors summarize recent advances in the science of RHD and sketch out priorities for current action and future research. Key questions for laboratory research into disease pathogenesis and epidemiological research on the burden of disease are identified. The authors present a variety of pressing clinical research questions on optimal RHD prevention and advanced care. In addition, they propose a policy and implementation research agenda that can help translate current evidence into tangible action. The authors maintain that, despite knowledge gaps, there is sufficient evidence for national and global action on RHD, and they argue that RHD is a model for strengthening health systems to address other cardiovascular diseases in limited-resource countries.en
dc.description.sponsorshipDr. Watkins has received support from the RHD Action grant from Medtronic Foundation outside of the submitted work. Dr. Carapetis has received funding from Novartis Institutes for Biomedical Research. Dr. Wyber has received funding from the Postgraduate Scholarship from the National Health and Medical Research Council (NHMRC), Australia, and from the Telethon Kids Institute. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.en
dc.description.statusPeer-revieweden
dc.format.extent20en
dc.identifier.issn0735-1097en
dc.identifier.otherPubMed:30213333en
dc.identifier.otherORCID:/0000-0003-3904-9269/work/163628951en
dc.identifier.scopus85052904387en
dc.identifier.urihttps://hdl.handle.net/1885/733795632
dc.language.isoenen
dc.rightsPublisher Copyright: © 2018 American College of Cardiology Foundationen
dc.sourceJournal of the American College of Cardiologyen
dc.subjectcardiac surgeryen
dc.subjectechocardiographyen
dc.subjecthealth servicesen
dc.subjectpathogenesisen
dc.subjectpreventionen
dc.subjectrheumatic heart diseaseen
dc.titleRheumatic Heart Disease Worldwide: JACC Scientific Expert Panelen
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage1416en
local.bibliographicCitation.startpage1397en
local.contributor.affiliationWatkins, David A.; University of Washingtonen
local.contributor.affiliationBeaton, Andrea Z.; Children's National Medical Centeren
local.contributor.affiliationCarapetis, Jonathan R.; Telethon Kids Instituteen
local.contributor.affiliationKarthikeyan, Ganesan; All India Institute of Medical Sciences, New Delhien
local.contributor.affiliationMayosi, Bongani M.; University of Cape Townen
local.contributor.affiliationWyber, Rosemary; Telethon Kids Instituteen
local.contributor.affiliationYacoub, Magdi H.; Aswan Heart Centreen
local.contributor.affiliationZühlke, Liesl J.; University of Cape Townen
local.identifier.citationvolume72en
local.identifier.doi10.1016/j.jacc.2018.06.063en
local.identifier.puref166a58f-bd97-4871-ae81-58c89016f3b4en
local.identifier.urlhttps://www.scopus.com/pages/publications/85052904387en
local.type.statusPublisheden

Downloads